Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 16, 2014

Total Value: $1.21B (100.0% shares, 0.0% debt)

Holdings (39)

— INTERMUNE INC 12.2%
Value $148M Shares 4,418,662 Share Price $33.47 Est. Cost/Share $15.49 Unrealized @ Report Date —
— AUXILIUM PHARMACEUTICALS INC 10.9%
Value $132M Shares 4,842,031 Share Price $27.18 Est. Cost/Share $17.45 Unrealized @ Report Date —
— CYBERONICS INC 9.2%
Value $112M Shares 1,711,730 Share Price $65.26 Est. Cost/Share $52.15 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 8.6%
Value $104M Shares 1,101,028 Share Price $94.03 * Est. Cost/Share $66.46 Unrealized @ Report Date +53.9%
— CUBIST PHARMACEUTICALS INC 8.3%
Value $100M Shares 1,369,211 Share Price $73.15 Est. Cost/Share $56.60 Unrealized @ Report Date —
— QUESTCOR PHARMACEUTICALS INC 5.2%
Value $62.95M Shares 969,495 Share Price $64.93 Est. Cost/Share $48.32 Unrealized @ Report Date —
— ABIOMED INC 4.7%
Value $57.35M Shares 2,202,289 Share Price $26.04 Est. Cost/Share $21.31 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 4.3%
Value $52.25M Shares 3,215,424 Share Price $16.25 * Est. Cost/Share $7.72 Unrealized @ Report Date +84.2%
BMRN BIOMARIN PHARMACEUTICAL INC 4.2%
Value $50.86M Shares 745,687 Share Price $68.21 * Est. Cost/Share $63.65 Unrealized @ Report Date +15.8%
STAA STAAR SURGICAL CO 4.0%
Value $48.76M Shares 2,593,653 Share Price $18.80 * Est. Cost/Share $8.10 Unrealized @ Report Date +99.0%
— KYTHERA BIOPHARMACEUTICALS I 3.0%
Value $35.99M Shares 905,259 Share Price $39.76 Est. Cost/Share $38.50 Unrealized @ Report Date —
— ANACOR PHARMACEUTICALS INC 2.6%
Value $31.46M Shares 1,572,078 Share Price $20.01 Est. Cost/Share $5.59 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 2.6%
Value $31.24M Shares 1,614,536 Share Price $19.35 Est. Cost/Share $22.29 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 2.4%
Value $28.68M Shares 3,634,984 Share Price $7.89 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 2.3%
Value $27.88M Shares 3,458,624 Share Price $8.06 Est. Cost/Share $6.82 Unrealized @ Report Date —
— SEQUENOM INC 2.0%
Value $23.98M Shares 9,788,442 Share Price $2.45 Est. Cost/Share $3.91 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 1.7%
Value $20.42M Shares 532,918 Share Price $38.31 * Est. Cost/Share $22.48 Unrealized @ Report Date +43.4%
— RIGEL PHARMACEUTICALS INC 1.7%
Value $20.06M Shares 5,169,301 Share Price $3.88 Est. Cost/Share $3.43 Unrealized @ Report Date —
— CELLADON CORP 1.5%
Value $17.78M Shares 1,491,500 Share Price $11.92 Est. Cost/Share $11.92 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.3%
Value $15.32M Shares 1,314,976 Share Price $11.65 Est. Cost/Share $14.69 Unrealized @ Report Date —
— NPS PHARMACEUTICALS INC 1.1%
Value $13.03M Shares 435,200 Share Price $29.93 Est. Cost/Share $30.36 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 1.1%
Value $12.95M Shares 186,900 Share Price $69.27 Est. Cost/Share $60.27 Unrealized @ Report Date —
— QLT INC 0.9%
Value $11.35M Shares 2,041,043 Share Price $5.56 Est. Cost/Share $4.40 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 0.9%
Value $11.02M Shares 777,676 Share Price $14.17 * Est. Cost/Share $12.83 Unrealized @ Report Date +5.3%
— OREXIGEN THERAPEUTICS INC 0.9%
Value $10.85M Shares 1,669,024 Share Price $6.50 Est. Cost/Share $6.50 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.7%
Value $8.221M Shares 3,971,576 Share Price $2.07 * Est. Cost/Share $3.07 Unrealized @ Report Date -18.6%
INSM INSMED INC 0.5%
Value $6.03M Shares 316,699 Share Price $19.04 Est. Cost/Share $11.32 Unrealized @ Report Date +67.9%
— SPECTRUM PHARMACEUTICALS INC 0.3%
Value $3.154M Shares 402,285 Share Price $7.84 Est. Cost/Share $7.48 Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 0.2%
Value $2.888M Shares 91,669 Share Price $31.50 Est. Cost/Share $31.50 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.2%
Value $2.348M Shares 247,186 Share Price $9.50 * Est. Cost/Share $6.71 Unrealized @ Report Date +34.7%
— AVEO PHARMACEUTICALS INC 0.2%
Value $2.137M Shares 1,429,174 Share Price $1.50 Est. Cost/Share $2.50 Unrealized @ Report Date —
— HYPERION THERAPEUTICS INC 0.1%
Value $1.618M Shares 62,700 Share Price $25.81 Est. Cost/Share $22.00 Unrealized @ Report Date —
— XOMA CORP DEL 0.1%
Value $1.334M Shares 256,100 Share Price $5.21 Est. Cost/Share $3.63 Unrealized @ Report Date —
GERN GERON CORP 0.1%
Value $1.06M Shares 507,300 Share Price $2.09 * Est. Cost/Share $3.99 Unrealized @ Report Date 0.0%
— SOPHIRIS BIO INC 0.1%
Value $975K Shares 292,900 Share Price $3.33 Est. Cost/Share $3.88 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 0.0%
Value $403K Shares 7,788 Share Price $51.75 * Est. Cost/Share $55.98 Unrealized @ Report Date 0.0%
— CELGENE CORP 0.0%
Value $362K Shares 2,590 Share Price $139.77 Est. Cost/Share $159.15 Unrealized @ Report Date —
— SHIRE PLC 0.0%
Value $267K Shares 1,800 Share Price $148.33 Est. Cost/Share $148.33 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 0.0%
Value $255K Shares 3,600 Share Price $70.83 * Est. Cost/Share $54.49 Unrealized @ Report Date 0.0%